These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome. Pappone C; Ciconte G; Manguso F; Vicedomini G; Mecarocci V; Conti M; Giannelli L; Pozzi P; Borrelli V; Menicanti L; Calovic Z; Della Ratta G; Brugada J; Santinelli V J Am Coll Cardiol; 2018 Apr; 71(15):1631-1646. PubMed ID: 29650119 [TBL] [Abstract][Full Text] [Related]
4. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis. Conte G; Sieira J; Sarkozy A; de Asmundis C; Di Giovanni G; Chierchia GB; Ciconte G; Levinstein M; Casado-Arroyo R; Baltogiannis G; Saenen J; Saitoh Y; Pappaert G; Brugada P Heart Rhythm; 2013 Dec; 10(12):1869-74. PubMed ID: 24055942 [TBL] [Abstract][Full Text] [Related]
5. A Report of Brugada Syndrome Presenting with Cardiac Arrest Triggered by Verapamil Intoxication. Yakut K; Erdoğan İ; Varan B; Atar İ Balkan Med J; 2017 Dec; 34(6):576-579. PubMed ID: 29215340 [TBL] [Abstract][Full Text] [Related]
6. Catheter Ablation of Brugada Syndrome: Importance of Repeated Administration of Ajmaline to Unmask the Entire Epicardial Substrate. Krieger K; Steinfurt J; Lenz C; Keweloh B JACC Clin Electrophysiol; 2017 Nov; 3(11):1330-1332. PubMed ID: 29759632 [No Abstract] [Full Text] [Related]
7. Is a drug-challenge test with propafenone adequate to exclude Brugada syndrome? Yildiz BS; Gungor H; Gul I; Bilgin M; Zoghi M; Akilli A Cardiovasc J Afr; 2013 Mar; 24(2):e4-6. PubMed ID: 23613002 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome. Cheung CC; Mellor G; Deyell MW; Ensam B; Batchvarov V; Papadakis M; Roberts JD; Leather R; Sanatani S; Healey JS; Chauhan VS; Birnie DH; Champagne J; Angaran P; Klein GJ; Yee R; Simpson CS; Talajic M; Gardner M; Yeung-Lai-Wah JA; Chakrabarti S; Laksman ZW; Sharma S; Behr ER; Krahn AD JACC Clin Electrophysiol; 2019 Apr; 5(4):504-512. PubMed ID: 31000106 [TBL] [Abstract][Full Text] [Related]
11. Epicardial substrate ablation for Brugada syndrome. Nademanee K; Hocini M; Haïssaguerre M Heart Rhythm; 2017 Mar; 14(3):457-461. PubMed ID: 27979714 [No Abstract] [Full Text] [Related]
12. ST-Segment Elevation and Fractionated Electrograms in Brugada Syndrome Patients Arise From the Same Structurally Abnormal Subepicardial RVOT Area but Have a Different Mechanism. Ten Sande JN; Coronel R; Conrath CE; Driessen AH; de Groot JR; Tan HL; Nademanee K; Wilde AA; de Bakker JM; van Dessel PF Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1382-92. PubMed ID: 26480928 [TBL] [Abstract][Full Text] [Related]
13. Unmasked Brugada pattern by ajmaline challenge in patients with myotonic dystrophy type 1. Pambrun T; Bortone A; Bois P; Degand B; Patri S; Mercier A; Chahine M; Chatelier A; Coisne D; Amiel A Ann Noninvasive Electrocardiol; 2015 Jan; 20(1):28-36. PubMed ID: 24943134 [TBL] [Abstract][Full Text] [Related]
15. Ajmaline challenge: to stop or not to stop.. Probst V; Le Marec H Heart Rhythm; 2009 May; 6(5):632-3. PubMed ID: 19389650 [No Abstract] [Full Text] [Related]
16. Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome. Batchvarov VN; Govindan M; Camm AJ; Behr ER Heart Rhythm; 2009 May; 6(5):625-31. PubMed ID: 19389649 [TBL] [Abstract][Full Text] [Related]
17. Pause-dependent normalization of ST-segment elevation during the ajmaline test in a patient with Brugada syndrome. Baranchuk A; Sicouri S; Elizari MV; Chiale PA Heart Rhythm; 2014 Apr; 11(4):707-9. PubMed ID: 24333924 [No Abstract] [Full Text] [Related]
18. Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome. Govindan M; Batchvarov VN; Raju H; Shanmugam N; Bizrah M; Bastiaenen R; Kiotsekoglou A; Camm J; Behr ER Heart; 2010 Dec; 96(23):1904-8. PubMed ID: 20962343 [TBL] [Abstract][Full Text] [Related]
19. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study. Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701 [No Abstract] [Full Text] [Related]